University of Wisconsin, Madison
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Wisconsin, Madison sits in the top decile of US sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count).
University of Wisconsin, Madison: 1,039 sponsored US clinical trials, 151 recruiting.
University of Wisconsin, Madison sponsors 1,039 registered US clinical trials on ClinicalTrials.gov, 151 of them currently recruiting, and 712 completed. 98 of these trials are in Phase 3-4 (later-stage) and 251 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 10 trials.
Top-decile sponsor footprint
University of Wisconsin, Madison ranks in the top decile of sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
712 of 824 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,039 total, page 14 of 21
Exploring the Use of Non-invasive Neuromodulation Combined With Exercise in People With Advanced Multiple Sclerosis (MS)
NCT02252666
Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)
NCT01963234
Media Diversion in Improving Quality of Life in Patients With Recurrent Gynecologic Cancers Receiving Chemotherapy
NCT01901835
Improving Knowledge of Medication in Ulcerative Colitis With an Iphone Application
NCT02120391
EURAD MRI Classification of US Indeterminate Adnexa Lesions
NCT02962596
Platelet-Rich Plasma (PRP) Injection for the Treatment of Chronic Patellar Tendinopathy
NCT01843504
Eicosanoid Lipids by Airway Cells During Infection With Human Rhinoviruses
NCT01898767
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
NCT01954420
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
NCT01999881
Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL
NCT01754857
Acute Lung Injury Ventilator Evaluation (ALIVE)
NCT01901354
A High Density EEG Comparison of Sleep Patterns in Insomnia
NCT01960452
Study: C-Collar and Dysphagia
NCT03349125
Enhanced Gait and Balance Training
NCT01896466
Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect Subjects
NCT01864642
A First-in-Human Safety and Dose-Finding Study of New Type-16 Human Rhinovirus (RG-HRV16) Inoculum in Healthy Volunteers
NCT01769573
Single vs Double Epidural Catheter Analgesia for Scoliosis Surgery
NCT01900626
"Stepping On" to Pisando Fuerte: Adapting an Evidence-Based Falls Prevention Program for Latino Seniors
NCT03895021
Exercise-induced Hypoalgesia After Comparative Forms of Exercise
NCT01883895
A Pilot Study: Treatment of Achilles Tendinopathy With Platelet-Rich Plasma Therapy
NCT01911650
Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight
NCT01828554
Games & Well-Being Study
NCT01886911
Availability of Lipid Emulsion to Regional Anesthesia Programs at US Academic Anesthesia Departments
NCT01880034
Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer
NCT01706458
Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT01707004
Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence
NCT01856712
NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis
NCT01816048
Brain Alterations and Cognitive Impairment in Older Adults With Heart Failure
NCT01821638
ACL Repair and Multimodal Analgesia
NCT01868425
Dane County Drug Court Study for Addicted Offenders
NCT01843751
Post Extubation Dysphagia
NCT01849679
An Interactive Web-based Intervention to Achieve Healthy Weight in Young Children
NCT01552642
Probiotics for Clostridium Difficile Infection in Older Adults
NCT01680874
Stress Reduction in Ovarian Cancer
NCT01790789
Premature Ventricular Contractions (PVCs) and Blood Pressure Control
NCT01833455
Meditation-CBT for Opioid-treated Chronic Low Back Pain
NCT01775995
Healthy Children, Strong Families: American Indian Communities Preventing Obesity
NCT01776255
A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab
NCT01743950
Helping Those With Mental Illness Quit Smoking
NCT01783912
Role of Nox2 in CNI-induced Renal Fibrosis
NCT01674465
University of Wisconsin Severe Asthma Research Program III
NCT01760915
Effects of Dexmedetomidine on Activity in the Subthalamic Nucleus
NCT01721460
Green Vegetables and Women's Health
NCT01726127
Neurophysiologic Correlates of Hypersomnia
NCT01719315
Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction
NCT01741454
A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast Cancer
NCT01808040
Vision Response to Dopamine Replacement
NCT01663935
Gulf War Illness Nasal Irrigation Study
NCT01700725
Impact of Manikin Training on Airtraq Avant Learning Curve in Predicted Difficult Airways
NCT01720017
Reduction of Obesity-Associated Intestinal Inflammation by Low-Fat Dairy Yogurt
NCT01686204
What is open in the University of Wisconsin, Madison pipeline
151 recruiting of 1,039 indexed (15% open); 712 completed (69%).
Phase mix: 98 late (III/IV) vs 251 early (I/II) (early-phase heavy).
Top condition: Healthy (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Wisconsin, Madison: open-pipeline peers nationwide
Peers matched on 1,039 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,039 trials (± recruiting share)
- University of Washington · 1,048 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Masonic Cancer Center, University of Minnesota · 14% recruiting · 249 trials
- ModernaTX · 14% recruiting · 90 trials
- United States Naval Medical Center, San Diego · 15% recruiting · 41 trials
- The Cleveland Clinic · 14% recruiting · 688 trials
Related
What to do with this University of Wisconsin, Madison page
1,039 registered trials is a research-attention snapshot, not an endorsement of University of Wisconsin, Madison or any single study.
- 151 of University of Wisconsin, Madison's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of Wisconsin, Madison studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Wisconsin, Madison pipeline card: 1,039 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.